It was found that the decrease in irisin is associated with an increased risk of presenting metabolic syndrome and hyperglycemia in obese adults, considering it to be protective against IR because it shows negative associations with fasting insulin and glycosylated hemoglobin [62]. Here, FNDC5 is linked to metabolic syndrome.